Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Flexi:Bak Clinical Trials By Jason Rosser D.O. & Associates Introduction Having designed the flexi:bak using his knowledge of anatomy and biomechanics, Jason Rosser D.O. carried out a series of tests to measure the pain-relieving effects of the product and its physical properties. The tests were carried out a) on himself, b) his associates and then c) on 224 new and long-term patients who attended the Osteopathic Clinic with a variety of conditions. These results pertain to the 224 patient trials. Organising the Tests Patients attending the Osteopathic Clinic were involved on a voluntary basis having been initially assessed by one of the three Osteopathic Associates. New patients had their case histories taken and diagnosis made. Patients were then briefed about the experiment and signed an agreement in which the whole procedure was again detailed. Acute & Chronic Acute Due to the obvious clinical restrictions in accurately diagnosing acute patients, especially if the condition is the result of a traumatic event or accident, it was decided to eliminate all acute lower back sufferers from this study. Initial symptoms of acute pain due to inflammation/swelling/muscle spasm only add to the complexity of an accurate diagnosis and therefore often ‘mask’ the underlying injury or disorder. These initial symptoms being short term can be seen as part of the ‘healing process’. Progress is frequently achieved with little or no therapeutic intervention. To accurately assess the influence of the flexi:bak on such individuals would be flawed at the outset. Chronic Lower back sufferers make up the majority of patients treated at the Osteopathic Clinic. The flexi:bak was designed and developed for the chronic sufferer and therefore the sample of patients involved in this study was limited to the chronic sufferer. Duration and make up of test The tests took place between 13 March 1998 and 12 March 1999 and involved 127 women and 97 men. Assessments 1. As the patients were the ones who would be questioned at the end of the trial, each was asked to give their subjective opinion of their pain levels. The scale was 0 = No Pain 1 = Occasional Pain 2 = Recurrent Pain less than 25% of the time 3 = Recurrent Pain more than 25% of the time/Constant Pain 4 = Severe Constant Pain 2. An assessment of specific joint and overall lower back mobility was carried out by Mr. Rosser and his associates. These used conventional Orthopaedic mobility tests which were: The SLR Schrober Foraminal Compression Hands-Feet Standing SI Gait-Walking The tests ascertained Lumbar Strain/Pain, Lumbar Facet Syndrome, Lumbar-Sacral Strain and Sacro-Iliac Dysfunction. Patients with more than one condition were marked in more than one category. This allowed the Assessor when carrying out the tests to give an ‘Active Range of Movement Figure’ for each test, based both on mobility and quality of movement. Each patient’s score was again valued 0-4 for each test. 0 = Full and complete mobility taking account of the patients age and overall state 1 = >20% Restriction 2 = >40% Restriction 3 = >60% Restriction 4 = >80% Restriction 3. Assessment of muscular spasm/guarding as an indicator of rate of recovery, confirmation of patient’s subjective pain report and indicator of soft-tissue state (namely circulation, swelling, and sensitivity) was also assessed on a grade 0-4. 0 = No muscle spasm in ‘lower triangle’. 1 = Increased muscle tone with increased superficial circulation. 2 = Muscle restriction affecting 1 or 2 lower triangle joints with obvious signs of inflammation and swelling. 3 = Painful restriction of 3 or 4 lower triangle joints with associated inflammation and swelling 4 = Severe and extensive muscle restriction affecting 4 or more lower triangle joints with soft tissue pain. Patient Pain Assessment Muscle spasm Foraminal Compression Active Range of Mobility Table 1. Overall Test Results 224 Persons Significant % Observable % Mild Improvemt Improvemt Improvemt Score =0 Score=1 Score=2 74 33.1 96 43.0 24 % No Change Scor=3/4 10.7 30 % 13.4 86 38.4 87 38.8 24 10.7 27 12.0 71 31.6 68 30.3 61 27.2 24 11.4 87 38.9 104 46.4 23 10.3 10 4.5 Patient Pain Assessment Muscle spasm Foraminal Compression Active Range of Mobility Table 2. Lumbar Sprain/Pain 81 Persons Significant % Observable % Mild Improvemt Improvemt Improvemt Score =0 Score=1 Score=2 23 28.3 41 50.6 5 6.2 No Change Scor=3/4 12 % 14.8 42 51.8 25 30.9 10 12.3 4 4.9 9 11.1 26 32.1 30 37.0 16 19.7 31 38.2 39 48.1 7 8.6 4.9 Table 3. Lumbar Facet Syndrome 30 Persons Significant % Observable % Mild Improvemt Improvemt Improvemt Score =0 Score=1 Score=2 14 46.7 10 33.3 4 Patient Pain Assessment Muscle 11 spasm Foraminal 15 Compression Active Range 12 of Mobility Patient Pain Assessment Muscle spasm Foraminal Compression Active Range of Mobility % 4 % No % Change Scor=3/4 13.3 2 6.7 36.6 13 43.3 4 13.3 2 6.7 50.0 8 26.7 5 16.7 2 6.7 40.0 12 40.0 5 16.7 1 3.3 % No Change Scor=3/4 14.5 14 % Table 4. Lumbar-Sacral Strain 77 Persons Significant % Observable % Mild Improvemt Improvemt Improvemt Score =0 Score=1 Score=2 23 30.2 29 38.2 11 18.4 18 23.4 24 31.2 20 26.0 15 19.5 35 45.4 24 31.2 12 15.6 6 7.8 27 35.0 37 48.1 10 13.0 3 3.9 Patient Pain Assessment Muscle spasm Active Range of Mobility Table 5. Sacroiliac Dysfunction 66 Persons Significant % Observable % Mild Improvemt Improvemt Improvemt Score =0 Score=1 Score=2 21 31.8 33 50.0 4 % 6.0 No Change Scor=3/4 8 % 12.1 16 24.2 21 31.8 20 30.3 9 13.6 28 42.4 31 46.7 4 6.0 4.5 3 Conclusion As a whole the group did experience a decrease in symptoms as a result of using the flexi:bak over the one month trial. The medical conditions of the patients in the study were of a chronic nature. The device helped these patients with the management of their pain as well as increased the functional range of motion in their problem areas or joint/s. By using patients with a chronic condition for this study it is reasonable to assume that the flexi:bak helped to reduce the related symptoms and findings. It is our belief that the results obtained in this study warrant further research. It is also important to note that there were no undesired manifestations as a result of using the flexi:bak